A Hong Kong fund’s acquisition proposal to Kobayashi Pharmaceutical’s founding family is reported to exceed ¥500 billion, and the founding family’s response has also been reported. It has also been reported that the former chairman will receive monthly compensation of ¥2 million.
It has been reported that a Hong Kong fund made an acquisition proposal to Kobayashi Pharmaceutical’s founding family, with the total value exceeding ¥500 billion, and that the founding family took a negative stance toward the proposal.
A separate report also says that the former chairman will receive monthly compensation of ¥2 million.